SCHEMBL404105

SCHEMBL404105

CC(=O)NC(C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22872710 0.78
SCHEMBL14157875 0.77
SCHEMBL3176034 0.75
SCHEMBL1938866 0.75
SCHEMBL13692 0.73
SCHEMBL3392039 0.73 KDM4E (0.50)
SCHEMBL3045315 0.73
SCHEMBL14157901 0.73 TRPV1 (0.46)
SCHEMBL23928748 0.73
SCHEMBL4173864 0.73 SLC7A5 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1090973-C Technetium-99m labeled peptides for imaging DIATECH INC (US) 2002-09-18 CN claimed
CN-1087630-C Radiolabeled compounds for imaging thrombi DIATECH INC (US) 2002-07-17 CN claimed
EP-0804481-A1 SOMATOSTATIN DERIVATIVES AND THEIR RADIOLABELLED PRODUCTS Diatide, Inc. (US) 1997-11-05 EP claimed
CN-1154071-A Radiolabeled compounds for imaging thrombi DIATECH INC (US) 1997-07-09 CN claimed
EP-0720621-A1 RADIOLABELED SOMATOSTATIN-DERIVED PEPTIDES FOR IMAGING AND THERAPEUTIC USES Diatide, Inc. (US) 1996-07-10 EP claimed
EP-0088977-B1 ELECTRON BEAM SENSITIVE RESIST GAF CORPORATION (US) 1988-06-01 EP claimed
EP-0126652-B1 ELECTRON BEAM SENSITIVE MIXTURE RESIST GAF CORPORATION (US) 1987-04-22 EP claimed
US-10920534-B2 Method for adjusting the level of inhibitors in an oil or gas well TOTAL SA (FR) 2021-02-16 US disclosed
US-20190264541-A1 METHOD FOR ADJUSTING THE LEVEL OF INHIBITORS IN AN OIL OR GAS WELL TOTAL SA (FR) 2019-08-29 US disclosed
EP-2723743-B1 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF TRIOPTOTEC GMBH (DE) 2019-08-14 EP disclosed
US-10329879-B2 Method for adjusting the level of inhibitors in an oil or gas well TOTAL SA (FR) 2019-06-25 US disclosed
EP-3084119-B1 METHOD FOR ADJUSTING THE LEVEL OF INHIBITORS IN AN OIL OR GAS WELL TOTAL SA (FR) 2019-04-24 EP disclosed
WO-2017040693-A1 BROAD SPECTRUM ANTIVIRAL COMPOUNDS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-03-09 WO disclosed
US-4623652-A ADRENERGIC BLOCKING AGENTS AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1986-11-18 US disclosed
EP-0093155-A4 ESTERS OF ARYLOXYPROPANOLAMINE DERIVATIVES AND USE AS BETA-ADRENERGIC BLOCKING AGENTS. AMERICAN HOSPITAL SUPPLY CORP (US) 1984-04-24 EP disclosed
EP-0093155-A1 ESTERS OF ARYLOXYPROPANOLAMINE DERIVATIVES AND USE AS BETA-ADRENERGIC BLOCKING AGENTS. AMERICAN HOSPITAL SUPPLY CORP (US) 1983-11-09 EP disclosed
WO-1983001772-A1 ESTERS OF ARYLOXYPROPANOLAMINE DERIVATIVES AND USE AS 'beta'-ADRENERGIC BLOCKING AGENTS AMERICAN HOSPITAL SUPPLY CORP (US) 1983-05-26 WO disclosed
EP-0038453-B1 PROCESS FOR THE PREPARATION OF WATER SOLUBLE PHTHALOCYANINE DYESTUFFS BAYER AG (DE) 1983-05-25 EP disclosed
EP-0001451-A1 Water-soluble azo-phthalocyanine fibre-reactive dyestuffs, their preparation and their use CASSELLA Aktiengesellschaft (DE) 1979-04-18 EP disclosed
US-3985835-A A PHOSPHORUS-HALOGEN-NITROGEN CONTAINING COMPOUND ALELIO GAETANO F D 1976-10-12 US disclosed